Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Oxford Parkinson’s Disease Centre

    Supports the Monument Discovery project.

  • Experimental Neurology Group

    This group, led by Professor Peter Brown, investigates the pathophysiology of Parkinson's disease, with the goal of developing new interventional treatments. It is funded by Parkinson's UK, the Medical Research Council, National Institute of Research Oxford Biomedical Centre and Rosetrees Trust.

  • sNN0031

    A Phase 2 RCT of intracerebroventricular administration of platelet-derived growth factor (pdGF) in PD. One of 5 European centres involved in the EU funded FP7 project. The Principal Investigators are Mr Alex Green and Dr Marko Bogdanovich.

  • Cognitive Neurology Group

    This group, led by Professor Masud Husain, works to understand and treat disorders of attention, memory, decision-making and motivation in patients with Parkinson’s disease, atypical Parkinsonian and other movement disorders. Research is supported by the Wellcome Trust, with clinics at the John Radcliffe and central Oxford.

  • Oxford Functional Neurosurgery

    This group is dedicated to the surgical alleviation of movement disorders such as Parkinson’s disease, dystonia, tremor and neuropathic pain syndromes.

  • Molecular Neurodegeneration Research Group

    This group, led by Associate Professor George Tofaris, aims to understand fundamental biological processes that could inform the development of targeted therapies in neurodegenerative and neurogenetic disorders.